Top News
Lenvatinib Plus Pembrolizumab Improves Survival in Advanced Endometrial Cancer
‘Practice-Changing’ Results With Sunitinib in Malignant Pheochromocytoma and Paraganglioma
Neoadjuvant CapeOx May Be Alternative to CRT in Locally Advanced Rectal Cancer
Some Cancer Drugs Without Proven Benefit Still Recommended
Interleukin-6 Levels May Predict PFS in Relapsed/Refractory Hodgkin Lymphoma Treated With Nivolumab
Prognostic Importance of Extramedullary Lesions in Multiple Myeloma
BNT162b2 Elicits Lower Antibody Levels Than mRNA-1273 Vaccine
Tivdak Approved for Recurrent or Metastatic Cervical Cancer
Cabometyx Approved for Radioactive Iodine-Refractory Differentiated Thyroid Cancer
TARE Prolongs PFS, Not OS, in Colorectal Cancer With Liver Metastases
High Rates of COVID-19 Mortality Seen in Patients With Hematological Malignancies
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
ESMO 2021 Coverage
Full coverage from the European Society for Medical Oncology (ESMO) Congress 2021. -
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease. -
IASLC 2021 Coverage
Coverage of the IASLC 2021 World Conference on Lung Cancer. -
SOHO 2021 Coverage
Full coverage of the 2021 Annual Meeting of the Society of Hematologic Oncology (SOHO). -
Trastuzumab Plus Chemotherapy Provides Long-Term Benefit for Early-Stage, HER2+ Breast Cancer
Trastuzumab reduced the 10-year risk of recurrence by 9%. -
Sex Inequalities Persist in Cancer Clinical Trials
Men nearly always outnumbered women, regardless of trial phase, cancer type, time period, or cancer incidence in the female population. -
Improving Black Representation in Oncology: ‘Be the Change’
Only 3% of medical oncologists in the United States are Black. -
Study Reveals Lack of Adherence to Treatment Guidelines in Non-Small Cell Lung Cancer
Patient age, treatment center, and tumor size were associated with a lack of adherence.
More Features
Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Experts Disagree on COVID-19 Vaccine Mandates for Health Care Providers
Experts outline benefits and detriments of COVID-19 vaccine mandates.
Lymphoma Patients Show Continued Cognitive Decline After Chemotherapy
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
Language in Patient Records Can Convey More Than Medical History
The language in a patient’s medical record can convey information not only about the patient’s condition but about the attitude of the clinician writing the report.
- Loading...
Loading...
Loading... 
Loading...